當前位置：首頁 JCRQ1 期刊介紹(非官網)

HpbSCIE

國際簡稱：HPB 參考譯名：血紅蛋白

中科院分區
3區
CiteScore分區
Q2
JCR分區
Q1

基本信息：: ISSN：1365-182X; E-ISSN：1477-2574; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：ENGLAND; 出版商：John Wiley and Sons Inc.; 出版語言：English; 出版周期：12 issues/year; 出版年份：1998; 研究方向：GASTROENTEROLOGY & HEPATOLOGY-SURGERY

評價信息：: 影響因子：2.7; H-index：62; CiteScore指數：5.6; SJR指數：1.141; SNIP指數：1.15

發文數據：: Gold OA文章占比：75.97%; 研究類文章占比：87.21%; 年發文量：172; 自引率：0.0344...; 開源占比：0.1; 出版撤稿占比：0; 出版國人文章占比：0.08; OA被引用占比：0.0421...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Hpb期刊介紹

HPB is an international forum for clinical, scientific and educational communication.

Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.

Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.

HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.

Abstracted and Indexed in:

MEDLINE?

EMBASE

PubMed

Science Citation Index Expanded

Academic Search (EBSCO)

HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).

期刊簡介Hpb期刊介紹

《Hpb》自1998出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：約1月
醫學
SURGERY
SCIE
中科院3區
非預警

Cite Score數據（2024年最新版）Hpb Cite Score數據

CiteScore：5.6
SJR：1.141
SNIP：1.15

學科類別	分區	排名	百分位
大類：Medicine 小類：Gastroenterology	Q2	44 / 167	73%
大類：Medicine 小類：Hepatology	Q2	30 / 82	64%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Hpb 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	3區	SURGERY 外科 GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	3區 4區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Hpb JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	64 / 143	55.6%
學科：SURGERY	SCIE	Q1	56 / 290	80.9%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	34 / 143	76.57%
學科：SURGERY	SCIE	Q2	74 / 290	74.66%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
USA227
CHINA MAINLAND82
Netherlands72
England70
Italy60
France57
Japan45
GERMANY (FED REP GER)37
Canada31
Australia26

本刊中國學者近年發表論文

1、Preoperative prediction model of microvascular invasion in patients with hepatocellular carcinoma
Author: Zhang, Jianfeng; Zeng, Fanxin; Jiang, Shijie; Tang, Hui; Zhang, Jian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 45-53. DOI: 10.1016/j.hpb.2022.08.007
2、Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China
Author: Yang, Shun-Chao; Liang, Lei; Wang, Ming-Da; Wang, Xian -Ming; Gu, Li -Hui; Lin, Kong-Ying; Zhou, Ya-Hao; Chen, Ting-Hao; Gu, Wei-Min; Li, Jie; Wang, Hong; Chen, Zhong; Li, Chao; Yao, Lan-Qing; Diao, Yong-Kang; Sun, Li -Yang; Zhang, Cheng-Wu; Zeng, Yong-Yi; Lau, Wan Yee; Huang, Dong-Sheng; Shen, Feng; Yang, Tian

Journal: HPB. 2023; Vol. 25, Issue 1, pp. 81-90. DOI: 10.1016/j.hpb.2022.09.002
3、Beyond successful hemostasis: CT findings and organ failure predict postoperative death in patients suffering from post-pancreatoduodenectomy hemorrhage
Author: Yang, Jie; Chen, Yonghua; Liu, Xubao; Zheng, Zhenjiang; Wang, Xing; Li, Yichen; Tan, Chunlu

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 252-259. DOI: 10.1016/j.hpb.2022.11.004
4、Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
Author: Lima, Henrique A.; Alaimo, Laura; Brown, Zachary J.; Endo, Yutaka; Moazzam, Zorays; Tsilimigras, Diamantis I.; Shaikh, Chanza; Resende, Vivian; Guglielmi, Alfredo; Ratti, Francesca; Aldrighetti, Luca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Hugh, Tom; Endo, Itaru; Shen, Feng; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 260-268. DOI: 10.1016/j.hpb.2022.11.008
5、Analysis of conditional survival in primary hepatocellular carcinoma after narrow-margin hepatectomy: a large- sample, dual-centre, retrospective study
Author: Kong, Jie; Huang, Tingfeng; Zhang, Jianxi; Tang, Shichuan; Liu, Hongzhi; Liu, Jingfeng; Zeng, Yongyi

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 179-188. DOI: 10.1016/j.hpb.2022.08.005
6、Predictive risk-score model to select patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy
Author: Endo, Yutaka; Moazzam, Zorays; Alaimo, Laura; Lima, Henrique A.; Munir, Muhammad M.; Shaikh, Chanza F.; Guglielmi, Alfredo; Aldrighetti, Luca; Weiss, Matthew; Bauer, Todd W.; Alexandrescu, Sorin; Poultsides, George A.; Kitago, Minoru; Maithel, Shishir K.; Marques, Hugo P.; Martel, Guillaume; Pulitano, Carlo; Shen, Feng; Cauchy, Francois; Koerkamp, Bas G.; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 2, pp. 229-238. DOI: 10.1016/j.hpb.2022.10.011
7、Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma
Author: Endo, Yutaka; Lima, Henrique A.; Alaimo, Laura; Moazzam, Zorays; Brown, Zachary; Shaikh, Chanza F.; Ratti, Francesca; Marques, Hugo P.; Soubrane, Olivier; Lam, Vincent; Poultsides, George A.; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Workneh, Aklile; Guglielmi, Alfredo; Hugh, Tom; Aldrighetti, Luca; Shen, Feng; Endo, Itaru; Pawlik, Timothy M.

Journal: HPB. 2023; Vol. 25, Issue 3, pp. 353-362. DOI: 10.1016/j.hpb.2022.12.009
8、Efficiency of percutaneous transhepatic cholangioscopy in the treatment of biliary complications after liver transplantation
Author: Yasen, Aimaiti; Feng, Jun; Liang, Run-Bin; Zhu, Can-Hua; Li, Jun; Liu, An-Zhong; Liu, Yan-Min; Wang, Guo-Ying

Journal: HPB. 2023; Vol. 25, Issue 4, pp. 463-471. DOI: 10.1016/j.hpb.2023.01.010